Dutch biotechnology company Molecular Biology Systems (MBS) today announced it will launch its revolutionary NEXTGENPCR thermal cycler in the US and Canada through Canon BioMedical, Inc., a wholly owned subsidiary of Canon U.S.A., Inc. focused on empowering the biomedical research and healthcare communities by developing, manufacturing, and marketing innovative technologies and solutions… Continue reading
Superfast cycler stuns genomics community with sub-2 minute protocols. Dutch biotechnology company Molecular Biology Systems(MBS) today reported major interest for its revolutionary NEXTGENPCR thermal cycler following the appearance of the first production models at the recent ESGH and LABVOLUTION meetings… Continue reading
Demand grows for superfast cycler after LABVOLUTION and ESHG showing. Dutch biotechnology company Molecular Biology Systems(MBS) today announced it has signed an exclusive distributor agreement for its revolutionary NEXTGENPCR thermal cycler with Isogen Life Sciences. This follows highly successful showings of the first production models at the recent ESHG and LABVOLUTIONS meetings. … Continue reading
